Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Shares Issued (2016 - 2025)

Ironwood Pharmaceuticals' Shares Issued history spans 15 years, with the latest figure at $122000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 39.9% year-over-year to $122000.0; the TTM value through Dec 2025 reached $216000.0, down 98.04%, while the annual FY2025 figure was $216000.0, 98.04% down from the prior year.
  • Shares Issued for Q4 2025 was $122000.0 at Ironwood Pharmaceuticals, up from $88000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $10.1 million in Q1 2024 and bottomed at $6000.0 in Q1 2025.
  • The 5-year median for Shares Issued is $1.5 million (2022), against an average of $2.6 million.
  • The largest annual shift saw Shares Issued surged 820.0% in 2021 before it tumbled 99.94% in 2025.
  • A 5-year view of Shares Issued shows it stood at $5.5 million in 2021, then plummeted by 49.39% to $2.8 million in 2022, then crashed by 64.43% to $998000.0 in 2023, then crashed by 79.66% to $203000.0 in 2024, then crashed by 39.9% to $122000.0 in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Shares Issued are $122000.0 (Q4 2025), $88000.0 (Q2 2025), and $6000.0 (Q1 2025).